World's Largest Diabetes Organization Discusses First Position Statement in Support of Surgery for Treatment of Diabetes for Obese Patients
WHAT:The International Diabetes Federation (IDF) will hold a press briefing to announce their first position statement on interventional therapies for Type 2 diabetes.
The IDF will urge the international community to consider bariatric surgery earlier in the treatment of eligible patients to help stem the serious complications that can result from diabetes. Dr. Herbert Pardes, president and CEO of NewYork-Presbyterian Hospital, will lead the press briefing at the Hilton NY.
WHO:Professor Paul Zimmet, Co-chair of the IDF Task Force on Epidemiology and Prevention; Director Emeritus, Baker IDI Heart and Diabetes Institute, Melbourne
Dr. Francesco Rubino, Chief of GI Metabolic Surgery at NewYork-Presbyterian/Weill Cornell; Director of the 2nd World Congress on Interventional Therapies for Type 2 Diabetes
Sir George Alberti, Co-chair of the IDF Task Force on Epidemiology and Prevention; Senior Research Investigator, Imperial College, London
Professor John B. Dixon, Head of Obesity Research Unit, Department of General Practice, Monash University, Melbourne
Dr. Herbert Pardes, President and CEO of NewYork-Presbyterian Hospital
Dr. Antonio M. Gotto Jr., Dean of Weill Cornell Medical College
WHEN:Monday, March 28 at 12:45 p.m.
WHERE:Hilton New York1355 Avenue of the Americas (at 53rd St.)Clinton Suite, Second Floor
RSS